SQZ Biotechnologies Company Profile Avatar - Palmy Investing

SQZ Biotechnologies Company

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Present…

Biotechnology
US, Watertown [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

SQZ Biotechnologies Company mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SQZ's Analysis
CIK: 1604477 CUSIP: 78472W104 ISIN: US78472W1045 LEI: - UEI: -
Secondary Listings
SQZ has no secondary listings inside our databases.